Skip to content

Clinical trials

Recruiting Carcinoma, Renal Cell trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Status: Recruiting Country / region: United States Clear all

139 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20151
20172
20181
20195
20201
202112
202217
202320
202418
202527
202632

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting139

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center9
National Cancer Institute (NCI)8
City of Hope Medical Center5
Mayo Clinic5
University of Texas Southwestern Medical Center5
Bristol-Myers Squibb4
Memorial Sloan Kettering Cancer Center4
Merck Sharp & Dohme LLC3
Regeneron Pharmaceuticals3
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell139
Carcinoma, Non-Small-Cell Lung39
Melanoma34
Kidney Neoplasms26
Colorectal Neoplasms22
Neoplasm Metastasis21
Squamous Cell Carcinoma of Head and Neck19
Carcinoma, Hepatocellular18
Carcinoma, Transitional Cell18
Ovarian Neoplasms14

Trials

Showing 1 to 25 of 139. Each trial links to its page on Pharma Observatory.

39 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.